Infigratinib in Patients With Recurrent Gliomas and FGFR Alterations
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study
Clin. Cancer Res 2022 Mar 28;[EPub Ahead of Print], AB Lassman, JM Sepúlveda-Sánchez, T Cloughesy, MJ Gil-Gil, VK Puduvalli, J Raizer, FYF De Vos, PY Wen, N Butowski, PMJ Clement, MD Groves, C Belda-Iniesta, P Giglio, HS Soifer, S Rowsey, C Xu, F Avogadri, G Wei, S Moran, P RothFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.